Disease: stage, non-small cell lung cancer ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0280217
Disease: stage, non-small cell lung cancer
stage, non-small cell lung cancer 		0.070 Biomarker disease BEFREE ERCC1_202 Is A Prognostic Biomarker in Advanced Stage Non-Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy. 28928874 2017
CUI: C0280217
Disease: stage, non-small cell lung cancer
stage, non-small cell lung cancer 		0.070 GeneticVariation disease BEFREE Association of ERCC1-C118T and -C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: a pooled analysis based on 39 reports. 23727606 2013
CUI: C0280217
Disease: stage, non-small cell lung cancer
stage, non-small cell lung cancer 		0.070 GeneticVariation disease BEFREE A C118T polymorphism of ERCC1 and response to cisplatin chemotherapy in patients with late-stage non-small cell lung cancer. 22102173 2012
CUI: C0280217
Disease: stage, non-small cell lung cancer
stage, non-small cell lung cancer 		0.070 GeneticVariation disease BEFREE We investigated whether single nucleotide polymorphism of excision repair cross-complementation group 1 C8092A affected the clinical outcomes and toxicity in advanced stage non-small cell lung cancer patients receiving first line platinum based chemotherapy. 21536539 2011
CUI: C0280217
Disease: stage, non-small cell lung cancer
stage, non-small cell lung cancer 		0.070 AlteredExpression disease BEFREE The goal of this study is to determine role of excision repair cross-complementing group 1 gene (ERCC1) and ribonucleotide reductase subunit M1 (RRM1) expression in predicting response and survival in Chinese patients with advanced stage non-small cell lung cancer (NSCLC) treated with platinum-based chemotherapy. 19488864 2010
CUI: C0280217
Disease: stage, non-small cell lung cancer
stage, non-small cell lung cancer 		0.070 Biomarker disease BEFREE RRM1 and ERCC1 are determinants of survival after surgical treatment of early-stage, non-small-cell lung cancer. 17314339 2007
CUI: C0280217
Disease: stage, non-small cell lung cancer
stage, non-small cell lung cancer 		0.070 AlteredExpression disease BEFREE We investigated whether ERCC1 mRNA expression levels were associated with clinical outcomes after treatment with a combination Gem/CDDP regimen for patients with advanced stage non-small cell lung cancer (NSCLC). 12114432 2002